Showing results (511-520 of 554) with videos related to
Sort By:
Pageof 56
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.Plos Pathogens|December 8, 2020
RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.Annals of the New York Academy of Sciences|January 14, 2022
Innovative vaccine approaches-a Keystone Symposia reportJennifer Cable, Rino Rappuoli, Elizabeth J Klemm, et al.Biorxiv : the Preprint Server for Biology|October 13, 2021
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.Plos Neglected Tropical Diseases|July 5, 2023
Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responsesRoshell Muir, Talibah Metcalf, Slim Fourati, et al.Immunity|July 22, 2018
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus GlycoproteinPavlo Gilchuk, Natalia Kuzmina, Philipp A Ilinykh, et al.Plos Pathogens|March 2, 2021
Correction: RV144 HIV-1 vaccination impacts post-infection antibody responsesThembi Mdluli, Ningbo Jian, Bonnie Slike, et al.Nature Biomedical Engineering|August 5, 2020
Integrated pipeline for the accelerated discovery of antiviral antibody therapeuticsPavlo Gilchuk, Robin G Bombardi, Jesse H Erasmus, et al.Nature Medicine|May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trialBoris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.Pageof 56